CARDIOPOLYMERS
CardioPolymers is a developer of an implantable device for treating congestive heart failure. It provides biocompatible polymer implant therapies to handle chronic heart failure, mitral valve regurgitation, and postoperative atrial fibrillation.
CARDIOPOLYMERS
Industry:
Health Care Medical Medical Device
Founded:
2002-05-14
Address:
Laguna Hills, California, United States
Country:
United States
Status:
Active
Similar Organizations
More informations about "CardioPolymers"
CardioPolymers 2025 Company Profile: Valuation, Investors
CardioPolymers General Information Description. Developer of an implantable device for treating congestive heart failure. The company provides biocompatible polymer implant therapies to โฆSee details»
CardioPolymers - Crunchbase Company Profile & Funding
Organization. CardioPolymers . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. CardioPolymers is a developer of an implantable device โฆSee details»
SYMPHONY MEDICAL CHANGES NAME TO CARDIOPOLYMERS, โฆ
About CardioPolymers, Inc. CardioPolymers, Inc., a Delaware Corporation ( formerly known as Symphony Medical ) was founded in 2003 and is headquartered in Orange County, California. โฆSee details»
CardioPolymers - Products, Competitors, Financials, Employees ...
CardioPolymers, formerly Symphony Medical, is a development-stage company focused on novel biocompatible polymer implant therapies to treat cronic heart failure, mitral valve regurgitation โฆSee details»
CardioPolymers, Inc. - Drug pipelines, Patents, Clinical trials
Explore CardioPolymers, Inc. with its drug pipeline, therapeutic area, technology platform, 1 literature.See details»
CardioPolymers - Headquarter Location, Corporate Office Address โฆ
CardioPolymers is Therapeutic Devices in United States that focus on biocompatible polymer business. Founded in 2002. They cover business area such as developer, congestive heart โฆSee details»
Cardiopolymers Inc - Company Profile and News - Bloomberg โฆ
Company profile page for Cardiopolymers Inc including stock price, company news, executives, board members, and contact informationSee details»
CardioPolymers (Symphony Medical) - Saints Capital
CardioPolymers (Symphony Medical) CardioPolymers (Symphony Medical) is focused on novel biocompatible polymer implant therapies to treat chronic heart failure, mitral valve regurgitation โฆSee details»
CardioPolymers, Inc.:Company Profile & Technical โฆ
CardioPolymers, Inc. is a company that provides Implant, Medicine, Polymer and more. CardioPolymers, Inc. is headquartered in United States California. CardioPolymers, Inc. was โฆSee details»
EIN 41-2044967 - Cardiopolymers, Inc., Laguna Hills, California
The Employer Identification Number (EIN) for Cardiopolymers, Inc. is 41-2044967. EIN numbers are also referred to as FEIN or FTIN. Find EIN, Contact Details for Cardiopolymers, Inc.. โฆSee details»
CardioPolymers - 2025 Company Profile - Tracxn
Mar 20, 2025 CardioPolymers - Develops biopolymer implant therapies to treat cardiac abnormalities. Raised a total funding of $13.6M over 1 round from 2 investors. CardioPolymers โฆSee details»
Intrinsically Conductive Polymers for Striated Cardiac Muscle Repair
One of the most important features of striated cardiac muscle is the excitability that turns on the excitation-contraction coupling cycle, resulting in the heart blood pumping function. The โฆSee details»
Cardiopolymers (Assignment for the Benefit of Creditors), LLC
View company leaders and background information for Cardiopolymers (Assignment for the Benefit of Creditors), LLC. Search our database of over 100 million company and executive โฆSee details»
Lonestar Heart acquires CardioPolymers - 2010-06-02 - Crunchbase
Jun 2, 2010 CardioPolymers CardioPolymers is a developer of an implantable device for treating congestive heart failure. Acquiring Organization: Lonestar Heart LoneStar Heart is a โฆSee details»
Polymeric Biomaterials for the Treatment of Cardiac Post โฆ
PLGA microparticles were used as a carrier of growth factors to simulate cell proliferation and organization in vessels . When applied in cardiac regeneration, PLGA microparticles loaded โฆSee details»
A Conductive Polymer Hydrogel Supports Cell Electrical Signaling โฆ
Aug 25, 2015 BackgroundโEfficient cardiac function requires synchronous ventricular contraction. After myocardial infarction, the nonconductive nature of scar tissue contributes to โฆSee details»
Elastomeric Polyesters in Cardiovascular Tissue Engineering and โฆ
Aug 28, 2023 Cardiovascular tissue constructs provide unique design requirements due to their functional responses to substrate mechanical properties and cyclic stretching behavior of โฆSee details»
Polymers in Cardiology - SpringerLink
Jan 1, 2014 Polymers as Coating Matrices for Drug-Coated Balloons (DCB) As alternative to DES DCB were developed since it was found that a single short exposure to PTX using non โฆSee details»
Biomimetic Polymers for Cardiac Tissue Engineering
Apr 13, 2016 Heart failure is a morbid disorder characterized by progressive cardiomyocyte (CM) dysfunction and death. Interest in cell-based therapies is growing, but sustainability of โฆSee details»
Elastomeric polyesters in cardiovascular tissue engineering and โฆ
Published in final edited form as: Biomacromolecules. 2023 Aug 28;24(11):4511โ4531. doi: 10.1021/acs.biomac.3c00387See details»